Indian patent office delivers major blow to affordable pneumonia vaccine hopes
Indian patent office granted a patent to Pfizer for its PCV13 product, marketed as Prevnar13. The granting of this patent would block other manufacturers in India from supplying this vaccine until 2026. Read more
THE NAKED TRUTH
The high prices of medicines sometimes stop our medical teams and others from giving the treatment we know can save lives. The pharmaceutical industry says the high prices they charge for medicines are down to the costs of research.
WATCH THE VIDEO
TPP: A BAD DEAL FOR MEDICINE
After 5 years of secret negotiations the US and 11 other Pacific countries have reached an agreement on the full text of the TPP which will now be submitted to national processes for final signature and ratification. Read MSF's reaction.
LEARN MORE
SNAPSHOT OF THE ACCESS CAMPAIGN IN 2017
MSF Access Campaign fights for our patients and others because medicines shouldn’t be a luxury. Learn more about our recent activities this year.
WATCH THE VIDEO
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond. We are a multi-disciplinary team that includes doctors, pharmacists, scientists, lawyers, as well as advocacy and communications experts. We also work with patient groups and other civil society organisations in response to their concerns over access to treatment.
Stories from the Field
- » HIV in Central African Republic: Patient Stories from Hôpital Communautaire
- » HIV in Central African Republic: "If you provide care, they will come."
- » Snakebite in South Sudan: Little hope of a cure for the most vulnerable
- » South Sudan: The Book that Traveled Too Much
- » Guinea: Screening for HIV in Conakry
- » Pakistan: Stories from patients cured from hepatitis C in MSF's Machar Clinic in Karachi
Featured Links
- » Issue brief - HIV & Opportunistic Infection Treatment: Spotlight on Access Gaps
- » Spotlight on USFDA neglected disease PRV
- » NEW R&D report: Lives on the Edge
- » 3P Project: Push, Pull, Pool
- » Spotlight on the TPP
- » Spotlight on RCEP
- » Patent Opposition Database
- » The Global Politics of Pharmaceutical Monopoly Power
